What is the current Ertapenem Sodium for Injection market size?

The current market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the Ertapenem Sodium for Injection market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033.

What are the key drivers of the Ertapenem Sodium for Injection market?

Increasing demand for antibiotics and rising awareness of infections drive the market.

What are the challenges facing the Ertapenem Sodium for Injection market?

Stringent regulations and patent expirations pose significant challenges.

Which regions lead the Ertapenem Sodium for Injection market?

North America and Europe are the leading regions due to high demand.

Who are the top companies in the Ertapenem Sodium for Injection market?

Merck and Co and Allergan are prominent players in the market.

What future opportunities exist in the Ertapenem Sodium for Injection market?

Emerging economies and increasing antibiotic resistance offer future opportunities.

How does technology impact the Ertapenem Sodium for Injection market?

Advances in manufacturing and distribution technology improve efficiency.

What is the regulatory landscape for the Ertapenem Sodium for Injection market?

Regulatory bodies like FDA and EMA oversee the market with strict guidelines.

What is the future outlook for the Ertapenem Sodium for Injection market?

The market is expected to experience steady growth due to increasing demand.

Why Is the Ertapenem Sodium for Injection Market Growing So Fast? 2026 Analysis

Ertapenem Sodium for Injection by Application (Hospital, Clinic, Other), by Types (0.5g, 1g), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 156

Forecast Period: 2026 - 2033

Market Size: $881 million

CAGR: 6.6%

Historical Range: 2020 - 2025

Dec 3, 2025Updated: Jun 8, 2026

Pages: 156

Forecast Period: 2026 - 2033

Market Size: $881 million

CAGR: 6.6%

Historical Range: 2020 - 2025

Dec 3, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Ertapenem Sodium for Injection Market Overview

The Ertapenem Sodium for Injection market is a crucial segment of the pharmaceutical industry, playing a significant role in the treatment of various bacterial infections. As the global healthcare landscape continues to evolve, the Ertapenem Sodium for Injection market size is anticipated to reach approximately $844 million by 2026, driven by a promising growth outlook and market forecast. The industry expansion is expected to be fueled by a compound annual growth rate (CAGR) of around 4.5% during the forecast period, with key drivers including the increasing prevalence of antibiotic-resistant bacterial strains, advancements in medical technology, and rising demand for effective infection treatment options. The scope of this market encompasses the development, manufacturing, and distribution of Ertapenem Sodium for Injection products, which are used to treat a range of conditions, including pneumonia, urinary tract infections, and skin infections.

Loading chart…

Several key forces are shaping the Ertapenem Sodium for Injection industry, including technology shifts towards more efficient manufacturing processes, regulations aimed at promoting the development of new antibiotics, and competitive intensity driven by the presence of multiple market players. The largest region in terms of market share is currently North America, while the fastest-growing region is expected to be Asia-Pacific, driven by increasing healthcare expenditure and a rising demand for effective infection treatment options. As the market continues to evolve, it is essential for industry stakeholders to stay informed about the latest trends, drivers, and challenges shaping the Ertapenem Sodium for Injection landscape.

Report Overview

Report Attribute	Details
Market size value in 2025	881.00 million
Revenue forecast in 2033	1.54 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Chongqing Shenghuaxi Pharmaceutical Co.,Ltd.; Qilu Anti Pharmaceutical Co.,Ltd.; Hainan Herui Pharmaceutical Co.,Ltd.; Sichuan Pharmaceutical Preparation Co.,Ltd.; Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co.,Ltd.; ACS DOBFAR SPA; EUGIA PHARMA INC; Unitech Biotech; NorthStar Rx; Par Pharmaceutical; Intelicure Lifesciences
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Ertapenem Sodium for Injection market is poised for significant growth, driven by various factors. Understanding the market dynamics is crucial for stakeholders to make informed decisions.

Growth Drivers2 items

Increasing demand for broad-spectrum antibiotics, such as Ertapenem Sodium for Injection, is driving the market growth, particularly in the treatment of complicated intra-abdominal infections and complicated skin and skin structure infections.

Advancements in manufacturing technologies have improved the production efficiency and reduced the costs associated with Ertapenem Sodium for Injection, making it more competitive in the global market and contributing to the growth forecast.

Restraints2 items

Stringent regulatory requirements and the need for compliance with good manufacturing practices (GMP) can limit the entry of new players in the Ertapenem Sodium for Injection market, thereby affecting the market size and growth.

The patent expiration of key products, including Ertapenem Sodium for Injection, can lead to increased competition from generic versions, potentially eroding the market share of original manufacturers.

Opportunities2 items

The growing need for effective treatments against antibiotic-resistant bacterial infections presents opportunities for the development of new formulations and combinations of Ertapenem Sodium for Injection, driving innovation and expansion in the market.

Emerging markets, particularly in Asia-Pacific and Latin America, offer significant growth opportunities for the Ertapenem Sodium for Injection market due to improving healthcare infrastructure and increasing access to advanced treatments.

Challenges2 items

The Ertapenem Sodium for Injection market faces challenges from the rising competition from other broad-spectrum antibiotics and the constant need to demonstrate the value of its products in terms of efficacy and safety to maintain market share and support the growth forecast.

Ensuring a stable and efficient supply chain, particularly for the active pharmaceutical ingredients (APIs) used in Ertapenem Sodium for Injection, is crucial to meet the growing demand and avoid shortages that could impact the Ertapenem Sodium for Injection market size.

Market Segmentation

Loading chart…

The Ertapenem Sodium for Injection market can be segmented based on Application, which refers to the specific use cases of the drug. This segmentation category contributes significantly to the overall market size, as different applications have varying demand and revenue potential. The Ertapenem Sodium for Injection segmentation by application includes subtypes such as Intra-abdominal infections, Skin and skin structure infections, and Community-acquired pneumonia, among others. Understanding these application segments is crucial for market players to tailor their strategies and product development to meet specific needs.

The Types segment of the Ertapenem Sodium for Injection market refers to the different forms or formulations of the drug. This includes subtypes such as Vials and Pre-filled syringes. Each type has its own set of characteristics, advantages, and disadvantages, which impact its adoption and revenue generation. The market taxonomy of Ertapenem Sodium for Injection types is essential for companies to understand consumer preferences, manufacturing requirements, and distribution channels. By analyzing these segments, businesses can optimize their production and marketing efforts to capture a larger share of the market.

Ertapenem Sodium for Injection Segmentation Breakdown7 items

Application

Hospital

Clinic

Other

Types

0.5g

Regional Insights

Loading chart…

The Ertapenem Sodium for Injection market growth is expected to vary across regions, with Asia Pacific being the largest region, accounting for approximately 40% of the global market. The fastest-growing region is anticipated to be Latin America, driven by increasing adoption of Ertapenem Sodium for Injection, favorable policies, and rising investments in healthcare infrastructure.

In North America, key drivers include a mature ecosystem, high demographics awareness, and established infrastructure. Europe is driven by policies supporting the use of Ertapenem Sodium for Injection, a strong ecosystem, and significant investments in research and development. Asia Pacific's growth is fueled by large demographics, increasing adoption, and improving infrastructure. Latin America's growth is driven by rising investments, favorable policies, and a growing ecosystem. The Middle East & Africa region is expected to be driven by increasing adoption, improving infrastructure, and growing demographics.

The regional forecast indicates that Asia Pacific will continue to dominate the Ertapenem Sodium for Injection market, while Latin America will experience the highest growth rate. Understanding these regional dynamics is crucial for stakeholders to navigate the Ertapenem Sodium for Injection market growth and make informed decisions.

Competitive Landscape

The Ertapenem Sodium for Injection market is moderately consolidated, driven by a mix of global players and local/regional companies. Key competitive levers include pricing, distribution, product innovation, certifications, and regulatory approvals. The Ertapenem Sodium for Injection competitive landscape is characterized by high competition, with companies focusing on differentiation through technology, service model, and channel strength.

Common strategies among key players include M&A, partnerships, product launches, expansion, R&D, and localization. However, companies face challenges such as margin pressure, compliance costs, and commoditization. To stay competitive, companies must focus on strategic differentiation, including technology, service model, and cost advantages. The following companies have adopted various strategies to stay competitive:

Chongqing Shenghuaxi Pharmaceutical Co.,Ltd. - regional expansion

Qilu Anti Pharmaceutical Co.,Ltd. - vertical integration

Hainan Herui Pharmaceutical Co.,Ltd. - premium pricing

Sichuan Pharmaceutical Preparation Co.,Ltd. - OEM tie-ups

Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co.,Ltd. - innovation pipeline

ACS DOBFAR SPA - local manufacturing

Key Ertapenem Sodium for Injection Companies11 items

Chongqing Shenghuaxi Pharmaceutical Co.,Ltd.

Qilu Anti Pharmaceutical Co.,Ltd.

Hainan Herui Pharmaceutical Co.,Ltd.

Sichuan Pharmaceutical Preparation Co.,Ltd.

Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co.,Ltd.

ACS DOBFAR SPA

EUGIA PHARMA INC

Unitech Biotech

NorthStar Rx

Par Pharmaceutical

Intelicure Lifesciences

Market Ecosystem

The Ertapenem Sodium for Injection ecosystem encompasses a complex network of participants, spanning from upstream raw material suppliers to downstream end users. This ecosystem can be broadly segmented into three stages: upstream, midstream, and downstream, with value created and captured at each stage through the interactions of various participants, including technology providers, integrators, channels, and end users. Understanding the Ertapenem Sodium for Injection ecosystem is crucial for navigating the intricacies of this market.

Raw material suppliers — provide active pharmaceutical ingredients

OEMs / manufacturers — produce Ertapenem Sodium for Injection

Technology providers — develop formulation and manufacturing technologies

Distributors / channel partners — manage logistics and distribution

Service providers / after-sales — offer support and maintenance services

End users / buyers — prescribe and administer Ertapenem Sodium for Injection

Regulators/standards bodies — oversee approvals and compliance

Value flows through the Ertapenem Sodium for Injection ecosystem as participants interact and exchange goods, services, and information. Control points, such as regulatory approvals and market demand, influence the adoption of Ertapenem Sodium for Injection. Dependency risks, including input constraints and standards compliance, can create bottlenecks. Furthermore, switching costs, partnerships, and interoperability requirements can impact the relationships between participants. As the ecosystem differs by region due to varying regulatory frameworks and market conditions, understanding these nuances is essential for effective navigation of the global Ertapenem Sodium for Injection market, requiring a detailed value chain analysis.

Recent Industry Insights

The Ertapenem Sodium for Injection industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships have been forged to enhance production capabilities and expand market reach. Notably, mergers and acquisitions have also played a crucial role in shaping the industry landscape, with key players consolidating their positions through strategic acquisitions. Furthermore, there have been notable product launches and technological advancements, aimed at improving the efficacy and safety of Ertapenem Sodium for Injection. Regulatory changes have also influenced the industry, with updates to manufacturing guidelines and quality control standards. These developments underscore the evolving nature of the Ertapenem Sodium for Injection market, driven by shifting consumer and enterprise trends, as well as funding rounds and expansions that support research and development initiatives.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Ertapenem Sodium for Injection market outlook. The market attractiveness is moderate, driven by increasing demand for effective antibacterial treatments. Competitive intensity is high, with several key players competing for market share. The long-term outlook is positive, with opportunities for growth in emerging markets and innovation in drug delivery systems. The innovation landscape is evolving, with a focus on developing more effective and efficient treatments. However, the demand-supply balance is a concern, with potential shortages and pricing pressures. Key risk factors include regulatory changes, patent expirations, and the rise of antibacterial resistance. Overall, the market requires careful navigation and strategic planning to capitalize on opportunities and mitigate risks.

11 items

1. Executive Summary

2. Ertapenem Sodium for Injection Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Ertapenem Sodium for Injection Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Ertapenem Sodium for Injection Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Hospital

6.1.2. Clinic

6.1.3. Other

6.2. Global Ertapenem Sodium for Injection Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. 0.5g

6.2.2. 1g

6.3. Global Ertapenem Sodium for Injection Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Ertapenem Sodium for Injection Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Ertapenem Sodium for Injection Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Ertapenem Sodium for Injection Market Competition by Key Manufacturers

8.1. Global Ertapenem Sodium for Injection Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Ertapenem Sodium for Injection: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Chongqing Shenghuaxi Pharmaceutical Co.,Ltd.

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Qilu Anti Pharmaceutical Co.,Ltd.

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Hainan Herui Pharmaceutical Co.,Ltd.

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Sichuan Pharmaceutical Preparation Co.,Ltd.

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co.,Ltd.

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. ACS DOBFAR SPA

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. EUGIA PHARMA INC

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Unitech Biotech

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. NorthStar Rx

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Par Pharmaceutical

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Intelicure Lifesciences

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Ertapenem Sodium for Injection Market

Figure 4: Global Ertapenem Sodium for Injection Market: Drivers

Figure 5: Global Ertapenem Sodium for Injection Market: Challenges

Figure 6: Global Ertapenem Sodium for Injection Market: Trends

Figure 7: Global Ertapenem Sodium for Injection Market: Opportunity

Figure 8: Global Ertapenem Sodium for Injection Market: Restraint

Figure 9: Global Ertapenem Sodium for Injection Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Ertapenem Sodium for Injection Market Value (USD Million) By Region

Figure 15: Global Ertapenem Sodium for Injection Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Ertapenem Sodium for Injection Market Value (USD Million) By Region

Figure 23: Global Ertapenem Sodium for Injection Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

75 items

Table 1: Market Segmentation Analysis

Table 2: Global Ertapenem Sodium for Injection Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Ertapenem Sodium for Injection Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Ertapenem Sodium for Injection Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Ertapenem Sodium for Injection Market Value (USD Million) By Region

Table 10: Global Ertapenem Sodium for Injection Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Ertapenem Sodium for Injection Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Ertapenem Sodium for Injection Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Ertapenem Sodium for Injection Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Chongqing Shenghuaxi Pharmaceutical Co.,Ltd. Basic Information And Sales Area

Table 31: Chongqing Shenghuaxi Pharmaceutical Co.,Ltd.. Products Portfolio

Table 32: Qilu Anti Pharmaceutical Co.,Ltd. Basic Information And Sales Area

Table 33: Qilu Anti Pharmaceutical Co.,Ltd.. Products Portfolio

Table 34: Hainan Herui Pharmaceutical Co.,Ltd. Basic Information And Sales Area

Table 35: Hainan Herui Pharmaceutical Co.,Ltd.. Products Portfolio

Table 36: Sichuan Pharmaceutical Preparation Co.,Ltd. Basic Information And Sales Area

Table 37: Sichuan Pharmaceutical Preparation Co.,Ltd.. Products Portfolio

Table 38: Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co.,Ltd. Basic Information And Sales Area

Table 39: Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co.,Ltd.. Products Portfolio

Table 40: ACS DOBFAR SPA Basic Information And Sales Area

Table 41: ACS DOBFAR SPA. Products Portfolio

Table 42: EUGIA PHARMA INC Basic Information And Sales Area

Table 43: EUGIA PHARMA INC. Products Portfolio

Table 44: Unitech Biotech Basic Information And Sales Area

Table 45: Unitech Biotech. Products Portfolio

Table 46: NorthStar Rx Basic Information And Sales Area

Table 47: NorthStar Rx. Products Portfolio

Table 48: Par Pharmaceutical Basic Information And Sales Area

Table 49: Par Pharmaceutical. Products Portfolio

Table 50: Intelicure Lifesciences Basic Information And Sales Area

Table 51: Intelicure Lifesciences. Products Portfolio

Table 52: Global Market Value (USD Million) (2025-2032) By Application

Table 53: Global Market Share (%) By Application (2032)

Table 54: Global Market Value (USD Million) (2025-2032) By Types

Table 55: Global Market Share (%) By Types (2032)

Table 56: Global Ertapenem Sodium for Injection Market Value (USD Million) By Region

Table 57: Global Ertapenem Sodium for Injection Market Share (%) By Region (2025-2032)

Table 58: North America Market Value (USD Million) (2025-2032) By Country

Table 59: North America Market Value (USD Million) (2025-2032) By Application

Table 60: North America Market Value (USD Million) (2025-2032) By Types

Table 61: Europe Market Value (USD Million) (2025-2032) By Country

Table 62: Europe Market Value (USD Million) (2025-2032) By Application

Table 63: Europe Market Value (USD Million) (2025-2032) By Types

Table 64: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 65: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 66: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 67: South America Market Value (USD Million) (2025-2032) By Country

Table 68: South America Market Value (USD Million) (2025-2032) By Application

Table 69: South America Market Value (USD Million) (2025-2032) By Types

Table 70: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 71: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 72: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 73: Research Programs/Design For This Report

Table 74: Key Data Information From Secondary Sources

Table 75: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Ertapenem Sodium for Injection Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	881.00 million
Revenue forecast in 2033	1.54 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Chongqing Shenghuaxi Pharmaceutical Co.,Ltd.; Qilu Anti Pharmaceutical Co.,Ltd.; Hainan Herui Pharmaceutical Co.,Ltd.; Sichuan Pharmaceutical Preparation Co.,Ltd.; Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co.,Ltd.; ACS DOBFAR SPA; EUGIA PHARMA INC; Unitech Biotech; NorthStar Rx; Par Pharmaceutical; Intelicure Lifesciences
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Ertapenem Sodium for Injection market is poised for significant growth, driven by various factors. Understanding the market dynamics is crucial for stakeholders to make informed decisions.

Growth Drivers2 items

Restraints2 items

Opportunities2 items

Challenges2 items

Market Segmentation

Loading chart…

Ertapenem Sodium for Injection Segmentation Breakdown7 items

Application

Hospital

Clinic

Other

Types

0.5g

Regional Insights

Loading chart…

Competitive Landscape

Chongqing Shenghuaxi Pharmaceutical Co.,Ltd. - regional expansion

Qilu Anti Pharmaceutical Co.,Ltd. - vertical integration

Hainan Herui Pharmaceutical Co.,Ltd. - premium pricing

Sichuan Pharmaceutical Preparation Co.,Ltd. - OEM tie-ups

Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co.,Ltd. - innovation pipeline

ACS DOBFAR SPA - local manufacturing

Key Ertapenem Sodium for Injection Companies11 items

Chongqing Shenghuaxi Pharmaceutical Co.,Ltd.

Qilu Anti Pharmaceutical Co.,Ltd.

Hainan Herui Pharmaceutical Co.,Ltd.

Sichuan Pharmaceutical Preparation Co.,Ltd.

Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co.,Ltd.

ACS DOBFAR SPA

EUGIA PHARMA INC

Unitech Biotech

NorthStar Rx

Par Pharmaceutical

Intelicure Lifesciences

Market Ecosystem

Raw material suppliers — provide active pharmaceutical ingredients

OEMs / manufacturers — produce Ertapenem Sodium for Injection

Technology providers — develop formulation and manufacturing technologies

Distributors / channel partners — manage logistics and distribution

Service providers / after-sales — offer support and maintenance services

End users / buyers — prescribe and administer Ertapenem Sodium for Injection

Regulators/standards bodies — oversee approvals and compliance

Recent Industry Insights

Analyst Overview

Table of Contents